JOEL WISE: Open Payments
NPI 1548752744 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$900 in 38 payments from 18 companies in 2025. Trend: 2023 $555 · 2024 $914 · 2025 $900
Food & beverage: $900
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 8 | $185 |
| Kerecis Limited | 5 | $143 |
| MIMEDX Group, Inc. | 2 | $87 |
| Otsuka America Pharmaceutical, Inc. | 4 | $76 |
| Lilly USA, LLC | 4 | $72 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $58 |
| ConvaTec Inc. | 1 | $40 |
| Lundbeck LLC | 1 | $35 |
| ANI Pharmaceuticals, Inc. | 1 | $32 |
| HARTMANN USA, INC. | 1 | $26 |
Products named: KRYSTEXXA, Kerecis SurgiClose, REXULTI, MOUNJARO, JOURNAVX, INNOVAMATRIX AC, VYEPTI, PURIFIED CORTROPHIN GEL.
Industry payments across TX — which companies pay providers there.
